Surgical removal of the index node marked using magnetic seed localization to assess response to neoadjuvant immunotherapy in patients with stage III melanoma.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 30882901.
- Also identified by DOI 10.1002/bjs.11168 and PMC identifier 6593699.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This pilot study explored the value of localized index node removal after neoadjuvant immunotherapy in patients with stage III melanoma, for use as a response indicator to guide the extent of completion lymph node dissection. Promising technology.
Medical subject headings
- Antineoplastic Agents, Immunological
- Ipilimumab
- Lymph Node Excision
- Melanoma
- Neoadjuvant Therapy
- Nivolumab